Clinical Trials on Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation in Luxembourg
Total 0 results
Nothing found
Sponsors and Collaborators
- Zahra Rabbani Khah
- Montreal Neurological Institute and Hospital
- Ionis Pharmaceuticals
- The Third Hospital of Changsha
- Mitchell Scheiman
- Health Parametrics Inc.
- Wushan County People's Hospital
- New York State Health Foundation
- European Network For Smoking and Tobacco Prevention
- Jeffrey W. Clark, MD
- Northern California Melanoma Center
- Marilia Medicine School
- Rex Bionics Plc
- CTC Bio, Inc.
- MingSight Pharmaceuticals Pty Limited
- Honda R and D Americas, Inc.
- Jeffrey Rudolph
- Medtronic Atrial Fibrillation Solutions
- Kawin Technology Share-holding Co., Ltd.
- John Granton
- View Full List
Medical Conditions
- Metastatic Spine Lesions
- Periferal Arterial Occlusive Disease, PAOD
- Primary Generalized Dystonia
- Fasting, Diet, Chemotherapy, Toxicity
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Hyperthyroidism, Autoimmune
- Renal Cancer Metastatic
- Ascaris Suum
- HDT-AHCT
- LSIL
- Pancreatic Neoplasms
- Brain MRI
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- Liver Hemangioma
- Pregnancy-Related Condition, Unspecified
- Waldenstrom's Macroglobulinemia Recurrent
- H.Pylori Infection
- Locally Advanced NSCLC
- ACTH-Secreting Pituitary Adenoma
- Advanced Esophageal Cancers
- View Full List
Drug Interventions
- Fludarabine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Hydroxychloroquine
- CKD-519
- Rifaximin
- Pentostatin
- Toripalimab plus Anlotinib
- Ombrabulin (AVE8062)
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Bendamustine
- Nimotuzumab
- AZD7798
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- 200 µg doxorubicin-containing MNA
- Levcromakalim
- ESK981
- Postoperative analgesia management
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Levobupivacaine, clonidine
- View Full List
CROs by country
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Chile
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Estonia
- Contract Research Organizations in France
- Contract Research Organizations in Hungary
- Contract Research Organizations in Italy
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Peru
- Contract Research Organizations in Portugal
- Contract Research Organizations in Slovakia
- CRO list by country